UCSF-Led Study Shows Promising Pre-Clinical Results in Killing Cancer Cells Resistant to Current KRAS-Targeted Treatments
The impact of climate change on human health has come to focus in recent years; however very little is known about the effect of climate change on chronic diseases like cancer. In the latest CureTalks podcast, we discuss climate change, the exposures it generates relevant to cancer, the challenges faced to measure this impact, and the potential disruption to health systems that are essential for cancer control.
A UC San Francisco-led team of international researchers has outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer.
Study Reveals Pregnant Women Are Exposed to Cancer-Causing Chemicals in Dishware, Hair Coloring, Plastics, and Pesticides
Pregnant women in the U.S. are being exposed to chemicals like melamine, cyanuric acid, and aromatic amines that can increase the risk of cancer and harm child development, according to a study from researchers at UC San Francisco and Johns Hopkins Bloomberg School of Public Health.
A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.
Dr. Hala Borno, a University of California, San Francisco (UCSF) oncologist and experienced health equity researcher, introduced a new, tech-enabled approach that prioritizes the need for diverse and underrepresented patient groups.
A new UC San Francisco study sheds light on the diversity within the most common type of pediatric liver tumor and suggests a way forward for more precise chemotherapy treatment.
Dr. Nola Hylton’s path to becoming one of the pre-eminent scientists in the field of biomedical imaging stretches back to childhood when she carried a deep curiosity about the world and “why things are as they are.” In this Q&A, Dr. Hylton talks about choosing a career that would have an impact on others, her enduring excitement for her work, and mentoring women of color in science.
T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UC San Francisco and Gladstone Institutes have rendered the therapeutic cells more resilient.
Katherine Van Loon, MD, and Jordyn Silverstein, MD, from UC San Francisco discuss the unique challenges pregnancy associated cancers (PAC) pose for women and their care teams, who must balance both safety of the mother and that of the fetus or embryo.
Dr. Jenna Lester founded the Skin of Color Program at UC San Francisco, which includes a training clinic that specializes in treating dark skin. There are just a handful of such clinics across the country, and Lester’s is the only one in Northern California.
A world-class team of researchers, co-led by UCSF’s Allan Balmain, and including Kim Rhoads and Luke Gilbert, has been selected to receive a $25M Cancer Grand Challenges award to investigate the very early stages of cancer development.
Announcing the Cancer Center See Us Portrait Project, a series of portraits and quotes by Black, Indigenous, People of Color (BIPOC) faculty and staff who are dedicated leaders in diversity, equity, and inclusion, and exhibit UCSF's PRIDE values.